Phase 1 SLE trials recruiting now

All SLE trials, every phase

Other phases for SLE

Phase 1 SLE trials

• A Study of APG-2575 in Patients With Mild-to-moderate Systemic Lupus Erythematosus.
  NCT06182969 · Phase: Phase 1, Phase 2 · Ages: 18 Years to 65 Years · Sex: Female · 1 location
• A Study of CLN-978, a Subcutaneously Administered CD19-directed T Cell Engager, in Subjects With Systemic Lupus Erythematosus
  NCT06613360 · Phase: Phase 1 · Ages: 18 Years to 70 Years · Sex: All (male and female) · 20 locations
• CD19-Directed Chimeric Antigen Receptor Autologous T Cells (CART19) for Lupus
  NCT06839976 · Phase: Phase 1, Phase 2 · Ages: 12 Years to 29 Years · Sex: All (male and female) · 1 location
• UC-MSC Cell Therapy Study for Systemic Lupus Erythematosus (SLE) Patients
  NCT06737380 · Phase: Phase 1 · Ages: 18 Years to 75 Years · Sex: All (male and female) · 1 location

Common questions

What does Phase 1 mean?

See how clinical trials work.

Is this list complete?

No. For the full record, search ClinicalTrials.gov.